| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 4,6500% | ₹175.1 0% | 800 | ₹1.25 -37.5% | 1,550100% |
| - | - | 840 | ₹2.25 0% | 7750% |
| 7750% | ₹131 0% | 850 | ₹4.65 102.17% | 48,825-25% |
| - | - | 860 | ₹6.85 104.47% | 22,4751350% |
| - | - | 870 | ₹8.2 0% | 5,4250% |
| 1,5500% | ₹104.8 0% | 880 | ₹9.3 89.79% | 76,72543.47% |
| - | - | 890 | ₹11.75 88% | 14,725-26.92% |
| 96,8753.30% | ₹55 -27.67% | 900 | ₹14.3 84.51% | 1,84,45015.53% |
| - | - | 910 | ₹17.5 84.21% | 15,500-9.09% |
| 16,2750% | ₹64 0% | 920 | ₹22.25 88.55% | 59,675-10.46% |
| 25,5753.12% | ₹33.75 -41.81% | 930 | ₹25.6 25.79% | 10,850600% |
| 43,4002700% | ₹28.85 -42.3% | 940 | ₹31.1 74.71% | 58,90049.01% |
| 1,55,00056.25% | ₹25.35 -37.79% | 950 | ₹36.8 69.58% | 36,425-26.56% |
| 2,82,87528.52% | ₹21.2 -39.25% | 960 | ₹41.05 58.8% | 1,13,150-2.01% |
| 1,64,30013.36% | ₹17.3 -41.84% | 970 | ₹49.35 59.7% | 70,525-9.90% |
| 1,51,90030.66% | ₹13.75 -45.1% | 980 | ₹56.45 57.46% | 94,5505.17% |
| 90,67574.62% | ₹11.25 -46.17% | 990 | ₹41.2 -1.19% | 31,7750% |
| 4,14,6254.69% | ₹9.5 -45.24% | 1,000 | ₹72.6 53.48% | 1,21,675-17.36% |
| 2,325200% | ₹7.2 -75.17% | 1,010 | - | - |
| 68,20012.82% | ₹6.25 -47.03% | 1,020 | ₹60 0% | 6,9750% |
| 6,2000% | ₹5.3 0% | 1,030 | - | - |
| 1,09,275-5.36% | ₹4 -48.71% | 1,040 | - | - |
| 34,100100% | ₹2.9 -53.96% | 1,050 | - | - |
| 54,250-12.5% | ₹2.55 -51.42% | 1,060 | - | - |
| 46,5005.26% | ₹1.55 -53.73% | 1,080 | - | - |
| 1,61,200-5.88% | ₹1.15 -48.88% | 1,100 | ₹135 0% | 2,3250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.